On [15] [16] September 1997, the U.S. Environmental Protection Agency sponsored the Conference on Preventable Causes of Cancer in Children. The conference was convened to examine rising trends in reported incidence of childhood cancer and the association of these trends with environmental exposures. This paper summarizes recommendations for future research offered by participants. These recommendations included more collaborative research integrating epidemiology, molecular biology, toxicology, and risk assessment; the development of better protocols for toxicologic testing including carcinogenicity using young animals; and research focused on specific periods of development during which susceptibility to environmental agents may be enhanced. Also recommended was enhanced use and development of molecular biomarkers for identification of susceptible populations, and documentation of exposures and effects in epidemiologic and toxicologic studies. Although toxicologic testing is considered essential to determine the effects of potential carcinogens on biological organisms, participants emphasized the need to link these findings with epidemiologic and exposure assessment research. Environ Health Perspect 106(Suppl 3): 867-873 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-3/ 867-873carroquino/abstract.html
Introduction
Each year in the United States, about 8000 medical advances have resulted in dramatic new cases of cancer are reported among reductions in the death rate from childchildren under 15 years of age. Although hood cancer, the occurrence of new cancer childhood cancer is a rare disease and cases among children has continued to rise during the last two decades. Reported incidence rates for all cancer sites combined in children have risen by about 10% in the 1974 to 1991 compiling period (1) , representing an average rate increase of about 1% (95% confidence interval, 0.6-1.3) per year (2) . The reported incidence of gliomas and acute lymphocyte leukemia, the two most common forms of cancer, rose by about 40 (3) and 5% (4) , respectively, for children in the under-15 age group. For a number of cancers (astroglial tumors, retinoblastomas, neuroblastomas, rhabdomyosarcomas, and acute lymphocytic leukemia), the reported increases in incidence appeared strongest for young children, especially those in the first through third years of life (2) . For other types of cancer, for which the number of cases is small, such as Wilms tumors and non-Hodgkin lymphoma, the trends in incidence are difficult to quantify. Wilms tumor increased by about 46% (3) for the same age group, and bone and joint cancers were up by about 16% in the 0 to 19 age group (3) . The causes of these reported increases in childhood cancer incidence have not been identified.
Most cancer results from the interaction between genetic factors and the environment (5, 6) . In this context, environment is defined broadly and includes diet, alcohol, drugs, tobacco, and all other nongenetic factors as well as classic environmental toxins. It has been estimated that about 80 to 90% of all cancers are attributable to environmental factors acting in conjunction with both genetic and acquired susceptibility (7) ; in infants and children the fraction of cancers due to environmental factors is probably somewhat lower than in adults. Most research efforts in recent years have been dedicated to the study of mechanisms of action of chemical carcinogens (8) . A major challenge of environmental cancer prevention is to document environment susceptibility interactions and then to translate this knowledge into public health interventions (7) .
In September 1997 as a consequence of the Clinton administration's commitment to reduce environmental health (11) . Studies are needed to determine which specific enzymes lead to changes in susceptibility in children to carcinogens and which of these enzymes are good predictors of children's susceptibility to cancer. The presence and activity of carcinogen-metabolizing enzymes during development from conception through adulthood should be studied. d) Study the variability in carcinogenmetabolizing enzymes in childhood populations and the role ofgeneticpolymorphisms in children s susceptibility to cancer.
There is great interindividual variability in the amounts and types of metabolizing enzymes, some of which are under direct genetic control (12) (13) (14) . For example, CYPlAI, whose product metabolizes polycyclic aromatic hydrocarbons (PAH) such as benzo [a] pyrene is a polymorphic enzyme. About 10% of the Caucasian population has a highly inducible form of the enzyme that is associated with increased lung cancer in smokers (7) . PAH-DNA adducts are also elevated in umbilical cord blood and placenta of newborns, with the CYPlAl MSP1 polymorphisms, which suggests that the genetic polymorphism may increase risk from transplacental PAH exposure (15) . Greater understanding of interindividual variations is key to understanding childhood susceptibility to cancer. e) Study the role ofgestational and preconception exposures that may result in increased exposure and/or susceptibility ofthe fetus to carcinogens.
More information is needed on the ability of certain carcinogenic compounds and/or their metabolites to cross the placenta. In addition, little information is available on the metabolic changes that occur during pregnancy and how they can affect the accumulation of carcinogens in the mother or the production of carcinogenic metabolites that could be transferred to the fetus. The metabolic capacity of the placenta also needs to be evaluated, as it can result in exposure of the fetus to toxic metabolites. Metabolizing enzymes can be induced by exposure to structurally related chemicals (16) , dietary factors (12) (13) (14) , and disease states (17, 18) . Furthermore, maternal exposure to environmental carcinogens can result in enzyme induction to the fetus (12) (13) (14) .
f) Evaluate the contribution ofcellproliferation to different types of childhood cancer, paying special attention to specific periods oforgan and tissue development during which accelerated cell proliferation may increase susceptibility to cancer.
Cell proliferation can contribute to an increased likelihood of carcinogenesis. For example, PAHs and aflatoxin B1 (AFB1) produce liver tumors when administered to newborn rodents but not when administered to older animals, presumably because the liver proliferates rapidly in the developing system but more slowly in older animals (19) . Women who were in their teens at the time of the atomic bombings had the greatest risk of radiation-induced breast cancer (20) . Because cells proliferate faster in children's bodies than in adults, cell proliferation may be a significant risk factor in childhood cancer. Some organs, such as the brain, are fully developed in early childhood, whereas others such as the skeletal system do not achieve maturity until adolescence (19) . This may be the reason why osteosarcoma, the most common bone cancer, peaks in late adolekcence, a period of rapid bone growth (21 (39) . By validating markers in this fashion, it becomes possible to use biomarkers in risk assessment to predict specific health effects. Because of the physiologic, metabolic, and developmental differences between children and adults, the relationship of exposure and effect biomarkers to other events of the continuum may be different between adults and children and should be evaluated. For example, newborns at delivery were found to have higher levels of PAH-DNA adducts in the blood than the mothers, despite the fact that transplacental exposure to the PAHs is estimated to be an order of magnitude or more lower than maternal exposure (40) . More Studies of susceptibility biomarkers such as the presence or absence of metabolic enzymes would provide information on the differential susceptibility of children versus adults. Because polymorphisms exist for many of the enzymes involved in carcinogen metabolism, biomarkers for these polymorphisms could potentially be used to identify subgroups of infants with greatest potential risks. Biomarkers for the presence of chemically inducible enzymes may also serve as indicators of multiple exposures. In addition, other types of susceptibility biomarkers such as the levels of certain nutritional elements can be used to identify subsets of infants at risk. Susceptibility biomarkers can potentially provide information on a wide range of susceptibility factors related to age, gender, ethnicity, degree of exposure, and health and nutritional status. c) Develop biomarkers that would detect maternal preconception exposures, transplacental exposures to thefetus, and early childhood exposures, e.g., biomarkers for passive smoking during theseperiods.
The reported increase in childhood cancer rates at younger ages suggests that environmental exposure during gestation and preconception may be involved. Experiments with a number of carcinogens (induding PAHs, nitrosamines, and AFB1) show that the risk of cancer is heightened if exposure begins in utero or in infancy rather than in adulthood (9, 41) . Therefore, it is necessary to emphasize the study of biomarkers that would detect maternal preconception exposures and transplacental exposures to the fetus. Biomarkers for early childhood exposures are also needed. d) Increase the use of biomarkers in qualitative and quantitative aspects ofrisk assessment.
Biomarkers can be used in several aspects of risk assessment. Sensitive biomarkers can be employed to assess early indicators of harm in human populations with suspected environmental exposure (39) . In hazard identification, the use of sensitive biomarkers can substitute for the need to use end points located at the extreme right of the exposure-disease continuum such as disease or tumor formation. Biomarkers can also provide information on the metabolic and physiologic differences between animals and humans, potentially eliminating the need for uncertainty factors. They can also be used for low-dose extrapolation. By (9) found that infants and children differ from adults in their exposures and susceptibilities, both qualitatively and quantitatively. The report indicated that children's exposure to pesticides are greater than those of adults because they eat more food, drink more water, and breathe more air per unit of body weight than adults do. For instance, the air intake of a resting infant is twice that of an adult under the same conditions. Infants and children drink more than 2.5 times as much water daily as adults do, relative to body weight (42) . During the first 6 months of life, children drink 7 times as much water per pound, and between the ages 1 through 5 years eat 3 to 4 times more food per pound than the average American adult (9) . In addition, their activity patterns and location further magnify exposure to pollutants. Hand-to-mouth behavior increases their ingestion of toxins in dust or soil and because they play close to the ground, they are exposed to toxins that form low-lying layers in Children's exposures through the father must also be studied. Exposure to pesticides in children of farmers occurs when pesticides are carried by the parents from the field into the home. Buckley et al. (43) found an association with acute lymphoblastic leukemia when both mother and father had been exposed to pesticides. The father's exposures may also contribute to the genetic syndromes that result in cancer, such as certain forms of retinoblastoma or Wilms tumor (22) . Animal studies suggest that paternal exposures to rats can affect subsequent cancer risk without altering fertility (44 of cancer, exposures at critical periods of development, such as when a tissue or system is rapidly developing, may greatly increase the child's susceptibility to cancer. k)Determine whether the techniques currently used to measure contaminant concentration and collect environmental samples that are representative ofa child's exposure. Develop protocols for environmental sampling that take into account the characteristics ofthe child's environment.
Environmental data is often the only available information to estimate exposures. It is necessary to determine whether the techniques currently used to measure contaminant concentrations and collect environmental samples are representative of a child's exposure. For example, air-monitoring measurements are currently taken at adult heights. These measurements may not be representative of the air quality closer to the ground, where children breathe. Thus, environmental sampling should take into consideration the specific characteristics of children's environments. 1 ) Identifj highly exposedpopulations. It is also recommended that research is done to target populations of children who are suspected to be more highly exposed (e.g., children of migrant farm workers). Collecting information from these research studies may help to identify some exposure factors from other chemicals. Information from unique cancer clusters (e.g., DES) could be better utilized to determine some children's exposure factors.
Summary
Preventable causes of childhood cancer were the focus of the conference. This is an area in which we still have much to learn. We do not yet know what fraction of childhood cancers are due to preventable causes. We are only beginningon the basis of imperfect knowledge-to develop strategies for prevention. The recommendations that were made at this conference and that are summarized in this report are intended to provide a blueprint for closing gaps in knowledge and thus for guiding prevention of childhood cancer. We aim for future progress in prevention equal to the progress in treatment of childhood cancers.
